These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1261 related articles for article (PubMed ID: 19699866)
21. A meta-analysis of the utility of pre-operative brain natriuretic peptide in predicting early and intermediate-term mortality and major adverse cardiac events in vascular surgical patients. Rodseth RN; Padayachee L; Biccard BM Anaesthesia; 2008 Nov; 63(11):1226-33. PubMed ID: 18673363 [TBL] [Abstract][Full Text] [Related]
22. N-terminal proBNP: a novel biomarker for the diagnosis, risk stratification and management of congestive heart failure. O'Donoghue M; Januzzi JL Expert Rev Cardiovasc Ther; 2005 May; 3(3):487-96. PubMed ID: 15889976 [TBL] [Abstract][Full Text] [Related]
23. Brain natriuretic peptide in heart failure and beyond. Mowla MM; Bustami BB Saudi Med J; 2006 Oct; 27(10):1457-61. PubMed ID: 17013463 [TBL] [Abstract][Full Text] [Related]
24. Complementary and incremental mortality risk prediction by cortisol and aldosterone in chronic heart failure. Güder G; Bauersachs J; Frantz S; Weismann D; Allolio B; Ertl G; Angermann CE; Störk S Circulation; 2007 Apr; 115(13):1754-61. PubMed ID: 17372171 [TBL] [Abstract][Full Text] [Related]
25. Amino-terminal pro-brain natriuretic peptide: a biomarker for diagnosis, prognosis and management of heart failure. Morello AM; Januzzi JL Expert Rev Mol Diagn; 2006 Sep; 6(5):649-62. PubMed ID: 17009901 [TBL] [Abstract][Full Text] [Related]
27. Outpatient monitoring and treatment of chronic heart failure guided by amino-terminal pro-B-type natriuretic peptide measurement. Troughton RW; Richards AM Am J Cardiol; 2008 Feb; 101(3A):72-5. PubMed ID: 18243863 [TBL] [Abstract][Full Text] [Related]
28. The additive value of N-terminal pro-B-type natriuretic peptide testing at the emergency department in patients with acute dyspnoea. van der Burg-de Graauw N; Cobbaert CM; Middelhoff CJ; Bantje TA; van Guldener C Eur J Intern Med; 2009 May; 20(3):301-6. PubMed ID: 19393498 [TBL] [Abstract][Full Text] [Related]
29. Decrease of plasma N-terminal pro beta-type natriuretic peptide as a predictor of clinical improvement after cardiac resynchronization therapy for heart failure. Ding LG; Hua W; Zhang S; Chu JM; Chen KP; Wang Y; Wang FZ; Chen X Chin Med J (Engl); 2009 Mar; 122(6):617-21. PubMed ID: 19323922 [TBL] [Abstract][Full Text] [Related]
30. Lowered B-type natriuretic peptide in response to levosimendan or dobutamine treatment is associated with improved survival in patients with severe acutely decompensated heart failure. Cohen-Solal A; Logeart D; Huang B; Cai D; Nieminen MS; Mebazaa A J Am Coll Cardiol; 2009 Jun; 53(25):2343-8. PubMed ID: 19539144 [TBL] [Abstract][Full Text] [Related]
31. Management of chronic heart failure guided by individual N-terminal pro-B-type natriuretic peptide targets: results of the PRIMA (Can PRo-brain-natriuretic peptide guided therapy of chronic heart failure IMprove heart fAilure morbidity and mortality?) study. Eurlings LW; van Pol PE; Kok WE; van Wijk S; Lodewijks-van der Bolt C; Balk AH; Lok DJ; Crijns HJ; van Kraaij DJ; de Jonge N; Meeder JG; Prins M; Pinto YM J Am Coll Cardiol; 2010 Dec; 56(25):2090-100. PubMed ID: 21144969 [TBL] [Abstract][Full Text] [Related]
32. Improved pharmacological therapy of chronic heart failure in primary care: a randomized Study of NT-proBNP Guided Management of Heart Failure--SIGNAL-HF (Swedish Intervention study--Guidelines and NT-proBNP AnaLysis in Heart Failure). Persson H; Erntell H; Eriksson B; Johansson G; Swedberg K; Dahlström U Eur J Heart Fail; 2010 Dec; 12(12):1300-8. PubMed ID: 20876734 [TBL] [Abstract][Full Text] [Related]
34. Increased adiponectin level in parallel with increased NT-pro BNP in patients with severe heart failure in the elderly: A hospital cohort study. Haugen E; Furukawa Y; Isic A; Fu M Int J Cardiol; 2008 Apr; 125(2):216-9. PubMed ID: 18234365 [TBL] [Abstract][Full Text] [Related]
35. Evidence for functional heterogeneity of circulating B-type natriuretic peptide. Liang F; O'Rear J; Schellenberger U; Tai L; Lasecki M; Schreiner GF; Apple FS; Maisel AS; Pollitt NS; Protter AA J Am Coll Cardiol; 2007 Mar; 49(10):1071-8. PubMed ID: 17349887 [TBL] [Abstract][Full Text] [Related]
36. Evolution of amino-terminal pro-B type natriuretic peptide testing in heart failure. Januzzi JL; Bayes-Genis A Drug News Perspect; 2009 Jun; 22(5):267-73. PubMed ID: 19609464 [TBL] [Abstract][Full Text] [Related]
37. B-type natriuretic Peptide-guided treatment for predicting outcome in patients hospitalized in sub-intensive care unit with acute heart failure. Valle R; Aspromonte N; Giovinazzo P; Carbonieri E; Chiatto M; di Tano G; Feola M; Milli M; Fontebasso A; Barro S; Bardellotto S; Milani L J Card Fail; 2008 Apr; 14(3):219-24. PubMed ID: 18381185 [TBL] [Abstract][Full Text] [Related]
38. B-type natriuretic peptide-guided versus symptom-guided therapy in outpatients with chronic heart failure: a systematic review with meta-analysis. De Vecchis R; Esposito C; Di Biase G; Ariano C; Giasi A; Cioppa C J Cardiovasc Med (Hagerstown); 2014 Feb; 15(2):122-34. PubMed ID: 24522083 [TBL] [Abstract][Full Text] [Related]
39. Natriuretic peptides in patients with atrial fibrillation and advanced chronic heart failure: determinants and prognostic value of (NT-)ANP and (NT-pro) BNP. Shelton RJ; Goode K; Cleland JG Europace; 2007 Feb; 9(2):147; author reply 148. PubMed ID: 17227813 [No Abstract] [Full Text] [Related]